ABBV-383
Product Specifications
Target
Integrin
Related Pathways
Cytoskeletal Signaling
Bioactivity
ABBV-383 (ABBV-383), a BCMA x CD3 bispecific T-cell engager (BiTE), targets and inhibits the B-cell maturation antigen (BCMA) while concurrently activating the T-cell surface glycoprotein CD3 complex. This compound is utilized in research focused on multiple myeloma, immunoglobulin light chain amyloidosis, and cardiovascular diseases.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/240554467194306629/TP2867
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items